HSS and General Atlantic are partnering to launch a national platform of ambulatory surgery centers focused on orthopedic and spine outpatient care, acquiring Legent Health to enhance patient access to specialized services.
Information on the Target
The Hospital for Special Surgery (HSS) is recognized as the nation’s leading orthopedic hospital, specializing in musculoskeletal health. Established in 1863, HSS has consistently maintained its prestigious ranking as No. 1 in orthopedics for 16 consecutive years, as recognized by U.S. News & World Report. The institution has achieved remarkable patient outcomes, including the lowest readmission rates nationwide for orthopedic procedures, along with impressively low infection and complication rates.
HSS not only excels in patient care but also leads in research and education within the field. The HSS Research Institute, with over 300 staff members, is at the forefront of advancing musculoskeletal health, focusing on tissue repair and regeneration. HSS aims to expand its reach through recent partnerships and innovations, ultimately making high-quality orthopedic and spine care more accessible.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the United States
The ambulatory surgery center (ASC) industry is experiencing significant growth in the United States, driven by an increasing demand for outpatient surgical procedures. ASCs offer a range of benefits, including lower costs, enhanced patient sat
Similar Deals
ChristianaCare → Crozer Health outpatient locations
2025
Prime Healthcare → Ascension facilities
2025
Gallant Capital Partners, LLC → Aero Turbine, Inc.
2025
Bain Capital → HealthEdge and UST HealthProof
2025
SK Capital → LISI Group Medical division
2025
General Atlantic
invested in
Legent Health
in 2025
in a Other Private Equity deal